Welcome to our dedicated page for Gelstat news (Ticker: GSAC), a resource for investors and traders seeking the latest updates and insights on Gelstat stock.
GelStat Corp (GSAC) delivers cutting-edge solutions in industrial security and venture banking through initiatives like its Intelligent Correctional Facilities Automation System (iCAS). This news hub provides investors and industry professionals with timely updates on corporate developments, financial milestones, and technological breakthroughs.
Discover official announcements ranging from strategic partnerships to product innovations in the security sector. Our curated updates include regulatory filings, leadership changes, and market expansion efforts that shape GSAC's position in investment banking and facility automation technologies.
Bookmark this page for direct access to primary source materials and analysis-free reporting on GSAC's activities. Regular updates ensure you stay informed about the company's progress in developing secure infrastructure solutions and managing venture capital portfolios.
GelStat Corporation (OTCPink: GSAC) has launched GSAC Engineering, a new division aimed at driving corporate growth as part of its turnaround plan. This initiative focuses on developing technology for industrial security and renewable energy. The company intends to secure intellectual property to enhance its competitive edge and is negotiating contracts with medium-tier security facilities in the southeastern U.S. CEO Javier Acosta expressed optimism about the new division's potential in shaping GelStat's future growth.
GelStat Corporation (OTCPink: GSAC) announced updates regarding its capital market activities, including a planned Regulation A+, Tier 2 equity financing of up to $5 million. The company has recouped over 100 million shares of common stock, which will enhance its treasury for future issuance. Outstanding shares have increased to approximately 618 million. CEO Javier Acosta indicated that these actions are aimed at simplifying the capital structure and pursuing growth. GelStat focuses on marketing non-prescription health products such as Migraine and Sleep formulations.
GelStat Corporation (OTCPink: GSAC) has received SEC qualification for a Regulation A+ public offering, aiming to raise up to $5 million. This funding will support marketing and the development of its OTC health products, including a homeopathic migraine solution and the reintroduction of its sleep product. The offering circular is available on the company's OTC Markets profile. CEO Javier Acosta emphasized the company's progress in restoring its status in the financial markets, focusing on product innovation in the multibillion-dollar health supplement sector.
FAQ
What is the current stock price of Gelstat (GSAC)?
What is the market cap of Gelstat (GSAC)?
